Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China flag China · Delayed Price · Currency is CNY
1.270
-0.010 (-0.78%)
Nov 13, 2026, 3:04 PM CST

SHE:000078 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
21,32626,66830,31736,41937,83541,054
Revenue Growth
-21.82%-12.04%-16.75%-3.74%-7.84%2.58%
Gross Profit
2,0302,4692,8323,5183,7764,394
Operating Income
-39.62254.72176.9618.73764.951,460
Net Income
-959.38-563.06-1,193-1,690-1,02793.3
Earnings Per Share
-0.36-0.21-0.45-0.64-0.390.04
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Distribution
16,48620,05723,56627,04430,426
Pharmaceutical Manufacturing
429.71445.79473.12503.01416.31
Health Products, Food
141.7123.4992.02127.12193.99
Medical Instruments
9,5559,58812,17910,0859,890
Unallocated Other
55.39102.93108.7776.08127.23
Total
26,66830,31736,41937,83541,054

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,8633,0983,6033,8983,7024,162
Total Debt
9,89611,70210,57811,40111,92212,580
Net Cash (Debt)
-8,033-8,604-6,975-7,502-8,220-8,418
Net Cash Growth
------
Net Cash Per Share
-3.05-3.27-2.65-2.85-3.13-3.20

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
90.78104.3939.54-410.19-64.33866.12
Capital Expenditures
-65.65-127.09-84.6-104.07-94.32-129.23
Free Cash Flow
25.13-22.7-45.06-514.26-158.65736.89
Free Cash Flow Growth
------50.98%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
9.52%9.26%9.34%9.66%9.98%10.70%
Operating Margin
-0.19%0.95%0.58%1.70%2.02%3.56%
Pretax Margin
-4.61%-1.87%-3.57%-4.00%-2.25%1.40%
Profit Margin
-4.50%-2.11%-3.94%-4.64%-2.71%0.23%
FCF Margin
0.12%-0.08%-0.15%-1.41%-0.42%1.80%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
-----104.08
Forward PE
-18.0818.0818.0818.0818.08
P/FCF Ratio
132.97----13.18
PS Ratio
0.160.340.220.240.240.24